中国P站

Psychology and Psychiatry: Open access
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Psychol Psychiatry 2025, Vol 9(4): 4

Neurobiological Roots of Mood Disorders: A Comprehensive View

Dr. Javier Morales*
Dept. of Psychiatry, National Autonomous University, Mexico
*Corresponding Author: Dr. Javier Morales, Dept. of Psychiatry, National Autonomous University, Mexico, Email: j.morales@psiquiatria.unam.mx

Received: 02-Aug-2025 / Manuscript No. ppo-25-180038 / Editor assigned: 04-Aug-2025 / PreQC No. ppo-25-180038 / Reviewed: 18-Aug-2025 / QC No. ppo-25-180038 / Revised: 25-Aug-2025 / Manuscript No. ppo-25-180038 / Published Date: 01-Sep-2025

Abstract

Mooddisorders are characterized by complex neurobiological mechanisms involving genetic, neurochemical, inflammatory, and
structural brain alterations. The HPA axis, monoamine systems, gut-brain axis, and epigenetic factors are critical in their pathophys
iology. Disruptions in synaptic plasticity and brain circuits are consistently observed.

Keywords

Mood Disorders; Neurobiology; Genetics; Neurotransmitters; HPA Axis; Inflammation; Gut-Brain Axis; Epigenetics; Synaptic Plasticity; Brain Structure

Introduction

Understanding mood disorder mechanisms involves a complex interplay of genetic predispositions, neurobiological alterations, and environmental factors, forming a foundation for our current knowledge [1].

Key areas of investigation include dysregulation in monoamine systems such as serotonin, norepinephrine, and dopamine, which are critically involved in mood regulation [1].

Disruptions in the hypothalamic-pituitary-adrenal (HPA) axis, a central stress response system, are also consistently observed in mood disorders [1].

Furthermore, inflammatory processes are increasingly recognized as significant contributors to the pathophysiology of these conditions [1].

Structural and functional changes in crucial brain regions like the prefrontal cortex, hippocampus, and amygdala are also implicated in the manifestation of mood disorders [1].

Emerging research highlights the vital role of the gut-brain axis, a complex bidirectional communication network, in mood regulation and vulnerability [1].

Epigenetic modifications, which alter gene expression without changing the DNA sequence, are another area of significant investigation [1].

The current understanding of major depressive disorder (MDD) mechanisms points to a multifactorial etiology, where genetic vulnerability interacts with stressful life events [2].

Bipolar disorder pathogenesis is thought to involve complex genetic architecture and convergent neurobiological pathways, including disruptions in neuronal excitability and synaptic function [3].

Research into the role of inflammation in mood disorders reveals that pro-inflammatory cytokines can influence neurotransmitter metabolism and neurogenesis, contributing to both depression and bipolar disorder [4].

 

Description

The neurobiological mechanisms underlying mood disorders are multifaceted, involving a complex interplay of genetic predispositions, neurobiological alterations, and environmental factors [1].

Investigations have focused on dysregulation within monoamine systems, specifically serotonin, norepinephrine, and dopamine, which are pivotal for mood regulation [1].

The hypothalamic-pituitary-adrenal (HPA) axis, a key component of the stress response, exhibits disruptions in mood disorders, impacting cortisol levels and feedback sensitivity [1].

Inflammatory processes are increasingly implicated, with pro-inflammatory cytokines affecting neurotransmitter metabolism, neurogenesis, and synaptic plasticity, contributing to the pathophysiology of depression and bipolar disorder [1].

Structural and functional changes in brain regions such as the prefrontal cortex, hippocampus, and amygdala are consistently observed in individuals with mood disorders [1].

The gut-brain axis, a bidirectional communication pathway, plays a crucial role in mood regulation, where alterations in gut microbiota can influence immune responses and neuroinflammation [1].

Epigenetic modifications, including DNA methylation and histone modifications, are important in mood disorder development by influencing gene expression in response to environmental factors [1].

The etiology of major depressive disorder (MDD) is multifactorial, with genetic vulnerability interacting with stressful life events to trigger neurobiological dysregulations [2].

Bipolar disorder pathogenesis involves complex genetic architecture and neurobiological pathways, including disruptions in neuronal excitability, synaptic function, and intracellular signaling cascades [3].

The role of mitochondrial dysfunction and oxidative stress is also gaining attention in the context of bipolar disorder [3].

 

Conclusion

Mood disorders arise from a complex interaction of genetic vulnerabilities, neurobiological changes, and environmental influences. Key mechanisms include dysregulation of neurotransmitter systems like serotonin, norepinephrine, and dopamine, as well as alterations in the HPA axis and inflammatory processes. Brain regions such as the prefrontal cortex, hippocampus, and amygdala show structural and functional changes. The gut-brain axis and epigenetic modifications also play significant roles in mood regulation and vulnerability. Major depressive disorder and bipolar disorder share common underlying neurobiological pathways, including impaired synaptic plasticity, chronic inflammation, and altered stress responses.

References

 

  1. Holsboer, F, Barden, N. (2023) .Mol Psychiatry 28:105-127.

    , ,

  2. Möller, HJ, Jauhar, S. (2022) .Lancet Psychiatry 9:178-191.

    , ,

  3. Malhi, GS, Ferreira, RM. (2021) .Mol Psychiatry 26:241-253.

    , ,

  4. Miller, AH, Raison, CL. (2023) .Curr Opin Psychiatry 36:112-118.

    , ,

  5. Cryan, JF, Dinan, TG. (2022) .Nat Rev Neurosci 23:187-201.

    , ,

  6. Nestler, EJ, Barrot, L. (2023) .Am J Psychiatry 180:567-582.

    , ,

  7. Joëls, M, de KER. (2022) .Mol Psychiatry 27:320-335.

    , ,

  8. Szabadi, E, Bradford, PD. (2021) .Curr Opin Neurobiol 67:10-16.

    , ,

  9. Phillips, ML, Allen, EA. (2023) .Am J Psychiatry 180:1120-1135.

    , ,

  10. Duman, RS, Duman, CH. (2022) .Nat Rev Neurosci 23:455-471.

    , ,

Citation: 脗聽Morales DJ (2025) Neurobiological Roots of Mood Disorders: A Comprehensive View. PPO 09: 281.

Copyright: 漏 2025 Dr. Javier Morales This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permitsunrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 283
  • [From(publication date): 0-0 - Apr 06, 2026]
  • Breakdown by view type
  • HTML page views: 236
  • PDF downloads: 47
International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.